Clinical Trial Update: GDNF Gene Therapy for Multiple System Atrophy [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating GDNF gene therapy for Multiple System Atrophy is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple System Atrophy

Drugs mentioned

• GDNF Gene Therapy (glial cell-derived neurotrophic factor (GDNF) gene therapy)

Snippet

Sponsor: Brain Neurotherapy Bio, Inc. | Conditions: Multiple System Atrophy | Phase 1 | Status: ACTIVE_NOT_RECRUITING